Protagonist Therapeutics
PTGX
PTGX
66 hedge funds and large institutions have $93.2M invested in Protagonist Therapeutics in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 31 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
52% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 31
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
66
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.85M | |
| 2 | +$1.68M | |
| 3 | +$1.15M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$870K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$823K |
Top Sellers
| 1 | -$6.59M | |
| 2 | -$3.6M | |
| 3 | -$2.31M | |
| 4 |
Renaissance Technologies
New York
|
-$1.33M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$878K |